MyAverix Finance
TWO · Healthcare
TTY Biopharm Co Ltd (4105)
Drug Manufacturers - Specialty & Generic
TTY Biopharm Co Ltd (4105) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4105
TTY Biopharm Co Ltd (4105) — FAQ
What is 4105's P/E ratio?
The price-to-earnings (P/E) ratio for TTY Biopharm Co Ltd (4105) is 18.00 (data as of 2026-03-23).
Does TTY Biopharm Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for TTY Biopharm Co Ltd (4105). Check the MyAverix Finance app for the latest dividend data.
What sector is TTY Biopharm Co Ltd in?
TTY Biopharm Co Ltd (4105) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 4105 listed on?
4105 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.